referees. Thus there lies the danger of only 'hot', novel studies being accepted. I say danger because nobody can predict with certainty if a modest reliable study may not stir the imagination of another scientist, with more technical knowledge and powerful tools, and lead to a major break-through.
Obsession with the Citation Index can be at times very tiresome and can lead to an exaggerated rejection rate. In theory, an absurd situation could arise where a journal publishes just one article a year, which is cited many times and the Citation Index would eclipse all of its competitors. This notwithstanding, the struggle for citation rates is sharpening and the problems linked with the Citation Index have to be dealt with.
How can we ensure that we properly accredit each other? I believe in creating an atmosphere with more courtesy and sense of responsibility in openly discussing the problem.
I have no power over other journals except to recommend that authors raise the problem with the Editor and authors in question. I myself sometimes write to authors who should/could have cited a paper from Leukemia hoping that this may help in subsequent publications. If the opportunity arises I may tactfully question the author of a 'forgetful' article.
I have received various replies ranging from not reading Leukemia to the paper having slipped from the file. On occasion I have been more successful and the author received subsequent recognition, which confirms the fact that oversight is more frequent than willful acts. Authors should be encouraged to inform the Editor, if their paper published in Leukemia is not cited.
What am I to do when the negligence stems from papers accepted under my editorship and published in Leukemia itself? So far, when the complaint is official and formulated as a Letter to the Editor, I naturally publish it in the journal. If it is formulated over the telephone or in private, I check the record of this paper and make a mental note. I shall in the future incorporate a recommendation to referees to be particularly attentive to the problem of references. This is probably superfluous as I am amazed at the diligence of our referees but it will be done nevertheless. As an aside I salute all referees (the cornerstone of a good journal) and particularly those prepared to spend time on an unknown author, editor, or publisher to whom they owe nothing and from whom they receve nothing.
As far as Leukemia is concerned, I shall reinstate a practice whereby authors are encouraged at the time of submission to make an extra effort to check they have cited all papers relevant to their studies, including those in Leukemia. It complicates our administration but it is of benefit to all parties including the authors themselves, who may in the future enjoy the same attention, if their paper be published in Leukemia. It can be considered as a safeguard for authors publishing in Leukemia. In summary, my colleagues and I consider the correct citation of authors, who have entrusted us with their studies, is a matter of good publication practice and good etiquette.
This procedure should not be considered a gimmick to increase the citation index. A few added references will not influence the standing of Leukemia as this figure is dependent on citation from all the other journals in the field. It would not justify the extra work involved.
Generally speaking, two options could be considered to improve apportionment of scientific credit. It has been suggested that the name of the database(s) consulted be mentioned as a footnote in the article. Another possibility may be to create under Correspondence a rubric for authors who consider their paper has been overlooked. It should have a slightly different form from a Letter to the Editor, but the reasons for claiming credit clearly stated, the tone kept courteous, and the decision to publish at the discretion of the Editors and authors. This could lead to fruitful discussions. The point is that authors are in my experience often bashful about voicing their frustrations, therefore hesitant to do it in writing.
I welcome all suggestions and comment and I would like to encourage all Editors to be attentive to the problem raised in this editorial. Competition for funds is getting harder everywhere, scientists more and more harassed, therefore render unto Caesar that which is Caesar's. Editor-in-Chief
